{"name":"Dragonfly Therapeutics","slug":"dragonfly-therapeutics","ticker":"","exchange":"","domain":"dragonfly.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE80NGNTbTZtSFRQdi1YVkNhQVhWVk9DWUZPMzhSZzcxbG8weWRHRlVYZTJJeU1fNG9NRXcxenRVM243V2l0VnlzNGpLQVQ4TlJZVXpQWktKXzlZWGc1RTNj?oc=5","date":"2026-01-16","type":"pipeline","source":"Nature","summary":"People - Nature","headline":"People","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9EckM1ZG13bndvUTBSODJUR0liQk9NSFktYVZnbjdkS200bjVWWW94N29pM09aU3dtN0dkaFhmLTJTa2ZSS0xCYnZ6VnlNU3lBeU1WNElPcm1NUElGN2taVlA0cmFIVXRwaUZFdXBKdW1kVGJWemRXQVMxUHg?oc=5","date":"2025-12-30","type":"pipeline","source":"Global Growth Insights","summary":"Who Are the Top 19 NK Cell Therapy Companies Globally? - Global Growth Insights","headline":"Who Are the Top 19 NK Cell Therapy Companies Globally?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9iVUFUYkF6aGt3akxZT0hGaW1LLTVITDlQdFFCYUZkc2IwaDJKSHZpQ1d2VmtPWldraV9yWm9idUZab0xqcWZzdXllQ1BIaF9WUGVxcFJMNWhPakFld2QzRVg2dElTbkZjVjdzcEY3QmtFRG96SzhTT25aMkY?oc=5","date":"2025-12-17","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Layoff Tracker 2025: Voyager jettisons 30 staffers; Mythic and Areteia shutter - Fierce Biotech","headline":"Fierce Biotech Layoff Tracker 2025: Voyager jettisons 30 staffers; Mythic and Areteia shutter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNbUhVVnJhLXVfekFiRzk1WDNXVFlKc2toSlZrOGRuNDgzS2YxYk1qU0lVZ2pEX0xzQWtQM1laMVRWQlBsZEFqSkw3dFNwQ2lyZzc4azdwNThlRHZyZGFrUzlVVGJGUDJsa2Y3MWE5M18zd3Z5THhsNGF4QmxCSnpKRkZ3UnNTak1HUmxaM0lSazJGTm13dHd1TEFhUTIxMUR0UTFtX180bw?oc=5","date":"2025-10-29","type":"pipeline","source":"Fierce Biotech","summary":"AbbVie halts development of Dragonfly cancer asset in midflight - Fierce Biotech","headline":"AbbVie halts development of Dragonfly cancer asset in midflight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQRGg3c3NfVW1qWmNFMi1KbXRGa1gxUEpIYV9iUkZrMXloN1VNY3VNcmQtaXpwZlhzLUZTdzBSQmZqODdXNVRiVzVrZFkyU3huUVlrWDFQblJtbkFValhBODUzTkliRjFZbERIa3hoLU1Za3B3NUlLQ203MWtZUGhuQ2JjWWQxSWNVN3I2Sw?oc=5","date":"2025-10-28","type":"trial","source":"Endpoints News","summary":"Regeneron discloses CRL; AbbVie stops work on Dragonfly asset - Endpoints News","headline":"Regeneron discloses CRL; AbbVie stops work on Dragonfly asset","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTFBMTXZQQ2MxTTJUYkRLdnROV2xuYWVNYm45dFlSWk15OXZqd0FENy1KeklBNlUzbFNLSjNZRjVsVWF2d05rSlRKUXFwRk9UYXViUzdHZzg4dElSUUNhaTVLNnhJYlk0MjMxQlh3NnNMN0NGT2lHelE?oc=5","date":"2025-09-19","type":"trial","source":"Oncology Pipeline","summary":"What now for NK-cell engagers? | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"What now for NK-cell engagers? | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxOWE1OZjRWekFFSzlqem9DcUduOWloUUc4bmJWQ3pBM2pYdUtiNEF2dFBITmFOU3FSQklNRjJSNEp4SWZFaG9ERXdJSWM1RTJYZXRITEprY0RQZk5zSV95N1pXZVVOc1kyMlhkdUgxT1VCd1NNSHlQY1ZmSWFlcExiVHV3MV9abE0?oc=5","date":"2025-01-27","type":"pipeline","source":"Pharma Voice","summary":"Natural killer cells, a rising alternative to CAR-T cell therapy - Pharma Voice","headline":"Natural killer cells, a rising alternative to CAR-T cell therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNa0RscDJZczYyNHFSU2NCcDlNQjlyQ3VoYkZ2OFZzQUUzYVpvdW1Jc3Q0WkdDbGFXUzlWeVliM2MzbDNMZ3VIZEU3WXlQUE9pUVV2NFVNa21VWEVkQURZa1hJTHh1WHkxN2VYX091aDJKUUhmaGtOd19Ca0ZGY2FpQzE2WUw3QWZoZ2xQUXpYeFN4czVockZoZEpMVkJDQWs?oc=5","date":"2024-08-05","type":"pipeline","source":"Contract Pharma","summary":"Dragonfly Therapeutics Taps Susan Altschuller as CFO - Contract Pharma","headline":"Dragonfly Therapeutics Taps Susan Altschuller as CFO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTFBDOHV1UHFDSFNjaEtQb3I2MUNZMjhOSzNreUhtU2hSVW9xNGQ1SVZ6Y1NLclpUWGlvcnRrZWwwWlVyTTlfbmZhNFIxb1F2TGd6eWpaWE9CWHgySUZRd3JBYjM4MnNvUFBKd0g0M3FqMWNmOUlKTVow?oc=5","date":"2024-06-30","type":"pipeline","source":"The Pharma Letter","summary":"Dragonfly Therapeutics - The Pharma Letter","headline":"Dragonfly Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOR0ZObHMxd3gwY1ZnYjBycGttMW15MjBOenRkWThLSWIwbE8za3o3NUI0RWItdkhmZHlPOHh5UkpLYmVuZ1U2cElheVdqdUNoQnl2aDB1TlQyUVptWVRvTEFBMWxsN2g2dXVmVWhETG1uVU9qaHJiUXdsT0EyMGNoYkNhc2RCU1RTQTlMRU5pbjY?oc=5","date":"2022-05-02","type":"deal","source":"BioPharma Dive","summary":"A cancer biotech attracts another deep-pocketed partner in Gilead - BioPharma Dive","headline":"A cancer biotech attracts another deep-pocketed partner in Gilead","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE5PRGZrc2JnYTFBbHR6bU0zdzNCR2l5cmZGdnhTc0F4NDBzSm5ubm9RQk5IVExyYWhyOFZDdTgxZEZ1bHVWbkFCSWs3VjN5VTM2d1A3V01GWUZxYllJanZKbjVxSWJUSzFhUEJsdG9yVFRCTkFzU0JtNlVCVQ?oc=5","date":"2020-08-18","type":"deal","source":"Pharmaceutical Technology","summary":"BMS signs $475m licensing deal with Dragonfly Therapeutics - Pharmaceutical Technology","headline":"BMS signs $475m licensing deal with Dragonfly Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQX2MtODF0emlpOWNSVlRMRFZEZ2hoY3BHT3JGckxaRERDZlpOaG5SNl9WTUJqN05ZVEJiTzMyYjVDTzhIS3ZhZGd4MWh1bldzdFpiM1UzN25QYlA5Z0lrbGgxRXo5b3A4UEpWTnRNZ1lVSEFVaGFITE1zbU1NVkduRXRxXy1Lc3NEWmtzZjRhRTdxb1Z5eHBHNlFJVWhBOXp3dmdhUWFuWDdNSU14NWc?oc=5","date":"2020-03-19","type":"pipeline","source":"PR Newswire","summary":"Dragonfly Therapeutics Completes New Investment Round - PR Newswire","headline":"Dragonfly Therapeutics Completes New Investment Round","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}